title: Lichenoid drug eruption associated with Bendamustine.
authors.affiliation: Department of Hematology and Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Kusano
authors.affiliation: Department of Hematology and Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Terui
authors.affiliation: Department of Hematology and Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Yokoyama
authors.affiliation: Department of Hematology and Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Hatake
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000069461:Bendamustine Hydrochloride / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions / Q000473:pathology*; D006801:Humans; D017512:Lichenoid Eruptions / Q000139:chemically induced* / Q000473:pathology*; D008224:Lymphoma, Follicular / Q000188:drug therapy / Q000473:pathology; D008297:Male; D012008:Recurrence; D000069283:Rituximab / Q000008:administration & dosage; D016879:Salvage Therapy / Q000009:adverse effects
chemical_list: D000069283:Rituximab; D000069461:Bendamustine Hydrochloride